Notable Research Findings

The most groundbreaking individual studies from the latest supplement and nutrition research — in plain language, with the evidence caveats built in. Research signals worth knowing about, not health advice.

A systematic review of 428 patients found Ginkgo biloba lowered eye pressure by just 1.5 mmHg (95% CI -7.1 to 9.6, P = 0.5) — a statistically null result that contradicts the popular belief it helps glaucoma.
- 2025-02-14
- Systematic Review
- n = 428
- PloS one
As one of the first systematic reviews to formally test this popular pairing, the null result strongly contests the prevailing belief that Ginkgo helps eye pressure — but the wide confidence interval and short follow-up (median 3.7 months) mean the question isn't fully closed.
Myth-busterGinkgo for Reduced Intraocular Pressure
Pomegranate supplementation linked to a 0.39 mmHg drop in diastolic blood pressure in a meta-analysis — but other heart risk markers didn't budge
- 2025-10
- Meta-Analysis
- n = 2,306
- Nutrition, metabolism, and cardiovascular diseases : NMCD
This is one of the first large-scale analyses to suggest pomegranate may lower diastolic pressure, but the effect is modest (less than half a millimeter of mercury) and the same analysis found no improvement in insulin resistance or waist-to-hip ratio, so the overall picture is still uncertain.
Big effectpomegranate for Reduced Diastolic Blood Pressure
Propolis mouthwash slashed cavity-causing bacteria by more than a factor of 10 in people with braces — but the effect may not translate to everyone.
- 2025-12
- RCT
- n = 120
- International orthodontics
This is one of the first rigorous trials to test propolis against cavity bacteria, and the result is unusually large — but until it's replicated in broader populations, consider it a promising early signal, not a settled fact.
Big effectPropolis for Reduced Streptococcus Mutans Levels
Saffron slashed white blood cell counts by over 4,000 units in sepsis patients — but only in a seven-day ICU trial with no effect on mortality.
- 2025-05-09
- RCT
- Nutrition journal
This is a striking signal from a small, short-term clinical study, but it's the first of its kind and didn't translate to a survival benefit, so the finding is intriguing but far from actionable for healthy people.
Big effectSaffron for Reduced White Blood Cell Count
A 90-day trial linked 500 mg/day quercetin to a large increase in a bone-formation marker — but also a similarly large increase in a bone-breakdown marker, leaving the net effect unclear.
- 2025-03-07
- RCT
- Journal of bone and mineral metabolism
This is among the first trials on quercetin for bone health in postmenopausal women, so the conflicting signals warrant caution — the supplement may accelerate bone turnover rather than protect against loss.
SurprisingQuercetin for Increased Osteocalcin Level
Propolis linked to 65% lower odds of chemo mouth sores in a meta-analysis — but the studies weren't blinded and the total evidence is still thin.
- 2025-04-07
- Meta-Analysis
- Endocrine, metabolic & immune disorders drug targets
This early meta-analysis suggests propolis might offer real relief for a painful side effect of chemotherapy, but the lack of blinding and small number of studies means the result is far from settled.
TrendingPropolis for Improved Oral Mucositis
A 544-patient meta-analysis found that pairing plant compounds like peony with standard psoriasis therapy dramatically outperformed standard care — with one compound cutting the PASI index by nearly 14 points — though peony's specific benefit was on immune markers rather than raw severity scores.
- 2026-06-22
- Systematic Review
- n = 544
- Frontiers in medicine
This is among the first indexed studies to systematically review peony for psoriasis, so the findings are promising but need replication — especially since the biggest severity score drop in the analysis came from a different plant compound.
Big effectPeony for Reduced Psoriasis Area and Severity Index
Ginkgo cut dizziness severity by 0.76 points on an 11-point scale in a meta-analysis — but nearly all the evidence came from dementia patients, leaving the real-world reach unclear.
- 2026-06-18
- Systematic Review
- Frontiers in neurology
This is the first systematic review to pull together multiple trials on ginkgo for dizziness in people with brain disorders, so it's a meaningful step forward — but the results come from a narrow patient group and the studies varied widely, so treat the finding as promising, not settled.
New evidenceGinkgo for Reduced Dizziness Severity
Eating 80 grams of sorghum daily for 12 weeks shrank visceral fat in Japanese adults with excess belly fat — but the same study found no effect on a liver enzyme tied to metabolic health.
- 2026-06-11
- Clinical Trial
- Nutrients
This is among the first clinical trials to test sorghum for visceral fat loss, so the finding is intriguing but far from settled — especially since it was a small, single-arm (uncontrolled) study in a specific population, and a related marker of liver stress didn't budge.
Surprisingsorghum for Reduced Visceral Fat
A 5-week trial of 10 g/day soy protein improved insulin sensitivity in overweight adolescent boys — but the effect is from a single, small study in a narrow population.
- 2026-06-23
- RCT
- Nutrients
This is early evidence that soy protein might help with insulin sensitivity, but with only one study in a specific group (overweight teenage boys) and a short duration, it's far from a universal recommendation.
New evidenceSoy Protein for Improved Insulin Sensitivity
A systematic review of 7 studies found no evidence that protein helps older adults with multiple chronic conditions build muscle — but only 2 of those studies actually tested protein.
- 2026-08
- Systematic Review
- n = 932
- Clinical nutrition ESPEN
This doesn't disprove protein's role in muscle health; it reveals that the existing research simply hasn't asked the right question in this specific population, so the popular belief that protein is a reliable muscle booster for all older adults is now contested for those with multiple long-term conditions.
Myth-busterProtein for Improved Muscle Mass
Coffee after C-section cut time to first gas by 2.75 hours in a meta-analysis — but the evidence rests on a small set of low-quality trials.
- 2026-02-04
- Meta-Analysis
- n = 555
- BMC public health
This is the first pooled analysis on coffee and post-surgical flatulence, and while the reduction is real in these studies, the underlying trials were small and unblinded, so the effect may shrink — or vanish — once better research comes in.
New evidenceCoffee for Reduced Flatulence
Black cohosh failed to beat placebo in two RCTs — a systematic review finds the evidence for hot flash relief is thin and mixed.
- 2026-06-23
- Systematic Review
- Nutrients
This null result undermines the popular belief that black cohosh reliably reduces menopausal hot flashes, but with only three studies total (one positive, two neutral), the picture is far from settled — the overall strength of the evidence is low.
Myth-busterBlack Cohosh for Reduced Vasomotor Symptom
Resveratrol lowered diastolic blood pressure by 3.55 mmHg in type 2 diabetes patients — a clean signal from a meta-analysis, but the benefit hasn't been tested in healthy people.
- 2026-04-15
- Meta-Analysis
- Nutrition journal
This is one of the first rigorous summaries to pin a specific, moderate-sized drop in diastolic pressure on resveratrol, but because the effect was seen only in people with type 2 diabetes, it's too early to assume the same would happen for someone without that condition.
Big effectResveratrol for Reduced Diastolic Blood Pressure
Ashwagandha slashed cortisol by a large margin in a meta-analysis of 1,706 adults — but the same study found no effect on TSH, T3, or estradiol.
- 2026-02-25
- Meta-Analysis
- n = 1,706
- Planta medica
This is among the first pooled analyses on ashwagandha and cortisol, so the result is promising but far from settled — especially since the underlying trials weren't blinded, which can inflate perceived benefits.
TrendingAshwagandha for Reduced Cortisol Levels
A meta-analysis tied higher coffee consumption to a 48% greater odds of heart attack — yet the same review found it protective against stroke and arrhythmia.
- 2026-05-07
- Meta-Analysis
- n = 2
- BMC cardiovascular disorders
This finding flips the usual narrative that coffee is mostly protective for the heart, but it comes from a tiny pool of just two studies and contradicts the review’s own results for other cardiovascular outcomes, so the picture is now contested rather than settled.
Myth-busterCoffee for Reduced Myocardial Infarction Risk
NAC plus hydration slashed contrast-kidney injury risk by 29% in a meta-analysis — but the data comes from clinical patients, not healthy supplement users.
- 2025-11-12
- Systematic Review
- n = 671
- Frontiers in medicine
For people undergoing contrast-dye procedures (like CT scans or angiograms), adding NAC to standard hydration meaningfully reduced acute kidney injury — but this is early evidence from a specific clinical population, not a general health recommendation.
Big effectN-Acetyl Cysteine for Reduced Contrast-Associated Acute Kidney Injury
NAC linked to a large rise in progesterone in women with PCOS — but the same meta-analysis found no effect on estradiol, FSH, or butyrate.
- 2025-01-14
- Meta-Analysis
- Nutrients
This is the first solid meta-analytic evidence tying NAC to progesterone in PCOS, but with only a handful of studies behind it, the finding is intriguing rather than definitive.
New evidenceN-Acetyl Cysteine for Increased Progesterone Level
Anthocyanins showed no link to lower obesity odds in a meta-analysis of 302 people — even as total flavonoids and isoflavones did in a much larger analysis.
- 2026-04-02
- Meta-Analysis
- n = 302
- BMC endocrine disorders
This tells us that, so far, the evidence for anthocyanins specifically is weak and inconclusive; don't treat this single small meta-analysis as the final word, but it does pop the bubble of any hype that 'all polyphenols work the same' for weight.
Myth-busterAnthocyanins for Reduced Obesity
A meta-analysis found that olive oil was tied to slightly higher systolic blood pressure than mixed nuts — a statistically significant difference (p<0.001) — while other heart risk markers showed no advantage for either option.
- 2025-11
- Meta-Analysis
- Nutrition, metabolism, and cardiovascular diseases : NMCD
This challenges the blanket assumption that olive oil is always the superior choice for heart health, but the finding is preliminary and based on a single meta-analysis where the olive oil group didn't actually worsen blood pressure on its own — it just didn't lower it as much as the mixed-nut group did.
Myth-busterOlive Oil for Increased Systolic Blood Pressure
Acute mountain sickness struck just 2% of quercetin users vs. 25% on placebo — but the trial included only 55 people.
- 2026-07-11
- RCT
- n = 55
- European journal of nutrition
This is among the first controlled studies linking quercetin to altitude sickness prevention, and while the effect is unusually large, it comes from a small, early-phase trial that needs independent replication before drawing firm conclusions.
Big effectQuercetin for Reduced Acute Mountain Sickness Incidence
In a meta-analysis of 424 hospitalized COVID-19 patients, NAC was tied to a 51% lower odds of death — but the results varied considerably across the 10 small trials.
- 2025-07-29
- Meta-Analysis
- n = 424
- Inflammopharmacology
This is a large effect from a moderately strong body of evidence (4 of 7 studies show benefit, none show harm), but the small total sample and moderate statistical heterogeneity mean the precise size of the benefit is still uncertain.
Big effectN-Acetyl Cysteine for Reduced Mortality Risk
A double-blind trial of 153 women with early-onset preeclampsia found that 600 mg/day of N-acetylcysteine did not significantly delay progression to severe disease — casting doubt on hopes for a low-cost option in resource-limited settings.
- 2026-06-17
- RCT
- n = 153
- PloS one
This is one of the first randomized trials testing NAC for this condition; the null result suggests it is not effective in this population, but the body of evidence is still too thin to draw a final conclusion.
Myth-busterN-Acetyl Cysteine for Reduced Time-to-Disease Progression
Curcumin cut BMI by 0.69 kg/m² in type 2 diabetes patients — but only at doses above 1,000 mg/day and in a clinical population.
- 2025-11-10
- Meta-Analysis
- n = 699
- Nutrition reviews
This is a moderately large effect for a supplement, but the evidence comes from a specific clinical group (type 2 diabetes), so results may not apply to people without the condition. Across 7 studies, most found a benefit, giving moderate confidence in the finding.
Big effectTurmeric for Reduced Body Mass Index
First systematic review ties vitamin E to NASH resolution in children with fatty liver — but dose and long-term effects remain unknown
- 2025-12-08
- Systematic Review
- n = 1,503
- BMC gastroenterology
This is early evidence from a single meta-analysis; while promising, the unspecified dose and clinical population mean the findings need replication before we can trust them broadly.
New evidenceVitamin E for Increased NASH Resolution
A meta-analysis of 1,257 stroke patients found L-DOPA had no effect on mood (SMD -0.10, 95% CI -0.30 to 0.10) — a null result that challenges the popular belief that boosting dopamine lifts spirits, though the finding is limited to a clinical population.
- 2026-04-03
- Meta-Analysis
- n = 1,257
- Neurorehabilitation and neural repair
This null result contradicts the common assumption that L-DOPA improves mood, but because it comes from a single meta-analysis in stroke rehabilitation — and is among the first studies on this pairing — the picture is far from settled, especially for healthy people or other conditions.
Myth-busterL-DOPA for Improved Mood
NAC failed to improve attention or any other cognitive measure in a 12-week trial of 481 children — despite promising mouse data.
- 2026-07
- RCT
- n = 481
- Pediatric neurology
This is the first large, rigorous test of NAC for attention in a clinical population, and the null result directly contradicts the hype from earlier animal studies — but because the trial was done in children with a specific genetic condition (neurofibromatosis type 1), the finding may not apply to healthy adults or other groups.
Myth-busterN-Acetyl Cysteine for Improved Attention Span
A meta-analysis of 16 studies found higher selenium tied to a 19% lower risk of colon cancer — but not for rectal cancer or colorectal cancer overall.
- 2026-04-07
- Meta-Analysis
- n = 16
- BMC public health
This is among the first meta-analyses to link selenium levels with colon cancer risk, but the same study failed to find a significant effect on rectal or overall colorectal cancer, so the result is intriguing but far from settled.
New evidenceSelenium for Reduced Colitis-Related Mortality
The only randomized trial on vitamin D for jaw pain found it worked no better than diclofenac — but that's based on a single study.
- 2026-06-23
- Systematic Review
- BMC oral health
This is the first systematic review to look at diet and temporomandibular disorder, but with just one small trial on vitamin D, the evidence is too thin to draw any conclusion — treat this as an early signal, not a settled answer.
New evidenceVitamin D for Reduced Pain Intensity
First review links low-bioavailable tocotrienols to white matter protection — but the evidence is still sparse
- 2025-06-30
- Systematic Review
- International journal of molecular sciences
This is among the first studies to flag a specific role for tocotrienols in brain structure, but because it's a scoping review of heterogeneous studies, it's a signal, not a conclusion.
New evidenceVitamin E for Improved White Matter Structural Protection